Testing early intensive rehabilitation after multiple sclerosis relapses
Tests early, specialized rehabilitation for adults recovering from a multiple sclerosis relapse.
Plain-language title generated from the registry record
Registry title: Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
Key facts
- Where
- Haslev and Ry, DenmarkSee the 2 sites
- Phase
- Phase 2
Where in Denmark
- The Danish MS HospitalsHaslev, DenmarkTaking people
- The Danish MS HospitalsRy, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Lars Hvid
- Trial code
- NCT06956326
- Record updated
- 4 May 2025
- Original description
The overall purpose of this project is to develop and test an infrastructure that can ensure early and specialized rehabilitation for individuals with multiple sclerosis (MS) on their path to recovery from a relapse. If this project proves successful, it can therefore help optimize clinical practice and provide a significant contribution to the treatment of relapsing-remitting sclerosis.Read full original descriptionShow less
Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
The overall purpose of this project is to develop and test an infrastructure that can ensure early and specialized rehabilitation for individuals with multiple sclerosis (MS) on their path to recovery from a relapse. If this project proves successful, it can therefore help optimize clinical practice and provide a significant contribution to the treatment of relapsing-remitting sclerosis.
Inclusion: admitted to the Danish MS Hospitals for an inpatient rehabilitation stay; confirmed motor relapse (within the past 6 months) by a neurologist, with disability/ functional interference characterized by change in pyramidal, and/or cerebellar functional scores of 2 or higher; completed steroid or other acute relapse treatment, if prescribed; age over 18 years.
Exclusion: medical conditions or substantial cognitive impairments that hinder participation in the study (e.g. inability to perform or understand the intensive rehabilitation); more than 6 months since onset of motor relapse; pregnancy.